These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17010443)

  • 1. Differentiating antidepressants of the future: efficacy and safety.
    Rosenzweig-Lipson S; Beyer CE; Hughes ZA; Khawaja X; Rajarao SJ; Malberg JE; Rahman Z; Ring RH; Schechter LE
    Pharmacol Ther; 2007 Jan; 113(1):134-53. PubMed ID: 17010443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
    Lader M
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):743-55. PubMed ID: 17624740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New options in the treatment of depression].
    Frieling H; Hillemacher T; Demling JH; Kornhuber J; Bleich S
    Fortschr Neurol Psychiatr; 2007 Nov; 75(11):641-52. PubMed ID: 17366379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in the pharmacological management of depression.
    Baldwin DS
    Hum Psychopharmacol; 2001 Dec; 16(S2):S93-S99. PubMed ID: 12404714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants and sexual dysfunction.
    Werneke U; Northey S; Bhugra D
    Acta Psychiatr Scand; 2006 Dec; 114(6):384-97. PubMed ID: 17087787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
    Pae CU; Marks DM; Masand PS; Peindl K; Hooper-Wood C; Han C; Mannelli P; Ciccone P; Patkar AA
    Clin Neuropharmacol; 2009; 32(2):85-8. PubMed ID: 19512961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations in CNS drug discovery: differentiating strategies to treat depression.
    Beyer CE; Hughes ZA
    Expert Opin Drug Discov; 2007 Oct; 2(10):1369-77. PubMed ID: 23484532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant agents for the treatment of chronic pain and depression.
    Jann MW; Slade JH
    Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of psychopharmacology of depression.
    Chang T; Fava M
    J Clin Psychiatry; 2010 Aug; 71(8):971-5. PubMed ID: 20797377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to the pharmacological management of major depressive disorder.
    Witkin JM; Li X
    Adv Pharmacol; 2009; 57():347-79. PubMed ID: 20230766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression.
    Kiss JP
    Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines and reality in practical use of and compliance to antidepressants in the treatment of depression: incidence survey in Lorraine and Champagne-Ardenne (France)].
    Hérique A; Kahn JP
    Encephale; 2009 Feb; 35(1):73-9. PubMed ID: 19250997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing new treatments for depression and anxiety.
    Chen Z; Yang J; Tobak A
    IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions.
    Seidman S
    Int J Impot Res; 2006; 18 Suppl 1():S33-8. PubMed ID: 16953246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of antidepressants: weighing the impact on treatment decisions.
    Schatzberg AF
    J Clin Psychiatry; 2007; 68 Suppl 8():26-34. PubMed ID: 17640155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depression: emerging therapeutics.
    Sen S; Sanacora G
    Mt Sinai J Med; 2008; 75(3):204-25. PubMed ID: 18704976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.